HOME >> BIOLOGY >> NEWS
AAAS jobs survey shows continuing salary growth in the life sciences sector, but women still earn less

Median salaries for U.S. life scientists increased 7 percent between May 2000 and May 2001, but women earn nearly one-third less than men, according to a survey completed by the American Association for the Advancement of Science (AAAS).

By comparison, real average weekly earnings for all U.S. workers rose 3.6 percent, seasonally adjusted, between August 2000 and August 2001, suggesting that salary increases within the life sciences sector continue to outperform raises for many other jobs.

The AAAS survey of 19,000 life scientists describes current compensation trends and identifies key issues affecting job satisfaction among researchers. Completed as a service for members of the non-profit AAAS, the world's largest general scientific organization, the jobs survey should prove useful to university administrators, corporate personnel directors and others working to improve recruitment and retention of U.S. life scientists.

An analysis of the findings, included in the 12 October issue of the AAAS weekly journal, Science, describes the survey as "the largest and most comprehensive examination yet attempted of salaries and job satisfaction among life scientists in the United States."

Life scientists are clearly among the nation's top earners: In August 2001, real average earnings for all U.S. workers--based on payroll reports from private, non-farm establishments--stood at $490.54 weekly (about $25,508 annually), according to U.S. Department of Labor (DOL) statistics. Last year, an evaluation of average annual pay to all U.S. workers covered by state and federal employment insurance programs set the average higher ($35,296 in 2000).

In contrast, the AAAS reports, academic life scientists are earning median salaries of $80,000 in 2001, while non-academics report salaries with a midpoint 20 percent higher than their academic counterparts-around $96,000.

But, male life scientists in academia earn median sala
'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
11-Oct-2001


Page: 1 2 3 4

Related biology news :

1. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
2. New survey reveals insights into unique relationship between mothers and pediatricians
3. AAAS 2004 salary survey: Despite long hours and low pay, life scientists love their work
4. Nations plant database falling behind, survey shows
5. AAAS survey: 80 percent of adults say were hurting oceans
6. Global wetlands surveyed from space
7. UC Berkeley museum biologists to repeat 85-year-old Yosemite National Park wildlife survey
8. Europeans and biotechnology survey of public perception
9. New physical activity opinion survey demonstrates perceptions do not meet reality
10. Genentech tops Science survey of best biopharma employers
11. Extensive research survey confirms life on Earth now being affected by global warming

Post Your Comments:
(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
(Date:10/17/2014)... This news release is available in German . ... for only a very few drugs. When treating overdoses, doctors ... Treatment is especially difficult if there is a combination of ... is playing and accidentally swallows his grandmother,s pills? ETH professor ... Zurich wanted to find an answer to this question. "The ...
(Date:10/16/2014)... managers have a new synthesis of recent research findings ... forests in the two states. , The Ecology ... and Washington: A Synthesis of the Relevant Biophysical Science ... report published by the U.S. Forest Service,s Pacific Northwest ... from managers for a synthesis of the large body ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by ... Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, ... to 2019” analyzes and studies the major market ... Asia-Pacific, and the Rest of the World (RoW). ... spread through 300 pages and in-depth TOC on ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: